Oncology
 |
|
14 november 2018 05:00:11 |
| Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma (British Journal of Cancer) |
|
Tweet |
| 94 viewsCategory: Oncology |
 Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts (British Journal of Cancer)Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
